• Citer

Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.

par Zambre, Y;Ling, Z;Chen, M.C.;Hou, Xue;Woon, C W;Culler, M;Taylor, J E;Coy, D H;Van Schravendijk, C.;Schuit, F;Pipeleers, Daniel;Eizirik, Decio L.
Référence Biochemical pharmacology, 57, 10, page (1159-1164)
Publication Publié, 1999

Article révisé par les pairs

• Détails
• Contenu

Titre:	Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.
Auteur:	Zambre, Y; Ling, Z; Chen, M.C.; Hou, Xue; Woon, C W; Culler, M; Taylor, J E; Coy, D H; Van Schravendijk, C.; Schuit, F; Pipeleers, Daniel; Eizirik, Decio L.
Informations sur la publication:	Biochemical pharmacology, 57, 10, page (1159-1164)
Statut de publication:	Publié, 1999
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Amyloid -- metabolism
	Humans
	Insulin -- metabolism
	Islets of Langerhans -- drug effects
	Islets of Langerhans -- metabolism
	Oligopeptides -- pharmacology
	Peptide Fragments -- pharmacology
	Peptides, Cyclic -- pharmacology
	Piperazines -- pharmacology
	Receptors, Somatostatin -- agonists
	Receptors, Somatostatin -- genetics
	Receptors, Somatostatin -- physiology
	Somatostatin -- analogs & derivatives
	Somatostatin -- pharmacology
	Somatostatin-28
	Somatostatin-Secreting Cells -- metabolism
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0006-2952
	info:pii/S0006-2952(99)00010-6
	info:pmid/11230804